Monossacáridos

b-D-Galactopyranosyl nitromethane is a high purity sugar with various modifications. It is custom synthesized to order and is available in various purity grades. This sugar can be modified by fluorination, glycosylation, methylation, or modification with oligosaccharides or monosaccharides. The CAS number for this sugar is 81846-64-2. b-D-Galactopyranosyl nitromethane High purity, Custom synthesis, sugar, Click modification, Fluorination, Glycosylation, Synthetic, Methylation, Modification, Oligosaccharide, Monosaccharide CAS No. 81846-64-2

2-Deoxy-D-glucono-1,5-lactone is a crystalline compound that is isolated from the hydrolysis of D-gluconic acid. This compound has been found to be a diastereoisomeric product with a lactone ring and an epimerization process. It can also be synthesized by reacting epichlorohydrin with potassium hydroxide in the presence of a hydroxy group. 2DG is an elimination product of 2-deoxyglucose and has been shown to have antihyperglycemic effects due to its ability to inhibit glucose synthesis in the liver and muscle cells. This compound also inhibits protein synthesis in bacteria, which may lead to cell death.

Methyl 2-azido-3,4,6-tri-O-acetyl-2-deoxy-bD mannoside is a custom synthesis that can be modified to suit the needs of the customer. It is an oligosaccharide and polysaccharide that has been modified with methylation and glycosylation. This product has CAS No. 97604-59-6 and is available for purchase in high purity with a purity level of at least 95%. Methyl 2-azido-3,4,6-triO acetyl -2 deoxy b D mannoside has been fluorinated to create a synthetic sugar.

1-Deoxy-1-nitro-L-glucitol is a potent apoptosis-inducing compound that has shown promising results in cancer research. It is an analog of vanillin and nintedanib, two well-known cancer cell inhibitors. 1-Deoxy-1-nitro-L-glucitol has been shown to inhibit the activity of several kinases, including those involved in tumor growth and progression. In addition, it has been found to be effective against various types of cancer cells, including Chinese hamster ovary cells and human bladder cancer cells. This compound also exhibits synergistic effects with other anti-cancer drugs such as glimepiride and apomorphine. The presence of 1-Deoxy-1-nitro-L-glucitol in urine may serve as a potential biomarker for the diagnosis and monitoring of certain cancers.

1,4:3,6-Dianhydro-L-iditol is a synthetic compound that is used in pharmaceutical preparations and tissue culture. It has been shown to inhibit the growth of bacteria such as Staphylococcus aureus and Mycobacterium tuberculosis in vitro assays. The synthesis of 1,4:3,6-dianhydro-L-iditol involves intramolecular hydrogenation of fatty acids with alkanoic acids and the use of solid catalysts.

2-Acetamido-6-azido-2,6-dideoxy-D-galactopyranose is a synthetic, unnatural monosaccharide bearing an azido biorthogonal reaction group. This compound can enter the cell and is processed by biosynthetic enzymes, in a manner similar to the natural O-linked N-acetyl-β-D-glucosamine. The glycans produced bear the azido functional group which can be chemically tagged with fluorescent dyes or biotin for visualisation or affinity.

Building block for chemical modification of GlcU, including glucuronylation

Octanoyl b-D-glucosylamine is a synthetic compound that has been designed for use in the synthesis of complex carbohydrates. It is an octanoyl derivative of D-glucosamine, which is a sugar. This compound can be used for the modification of saccharides and polysaccharides, as well as sugars. It has been shown to be resistant to glycosylation and fluorination reactions.

4-Methoxyphenyl b-D-galactopyranoside is a custom synthesis of a sugar with an active methyl group. It is synthesized by the Click modification of 4-hydroxyphenyl b-D-galactopyranoside and has been fluorinated. The glycosylation process has been carried out using glycone as a precursor to modify the monosaccharide and oligosaccharide. This product has a CAS number of 3150-20-7 and is considered a synthetic compound.

Glucose is a monosaccharide that is an important source of energy for the human body. It is a simple sugar found in many carbohydrates and is the main form of fuel used by the brain. Glucose is also used as a chemical building block for polysaccharides such as glycogen, cellulose, and chitin. The hypoglycemic effect of glucose can be observed when blood glucose levels are below 70 mg/dL. This effect can be due to its ability to increase the production of insulin or decrease the rate of gluconeogenesis in liver cells. It also has been shown to have an inhibitory effect on some viruses and bacteria, which may be due to its ability to inhibit transcription activators or polymerase chain reactions.

3-Acetamido-3,6-dideoxy-D-galactose is a monosaccharide with two functional groups. It has been shown to be bifunctional and can act as a glycosyl donor or acceptor. 3-Acetamido-3,6-dideoxy-D-galactose was isolated from the type strain of Streptomyces venezuelae. It is also found in fatty acids and some strains of bacteria, such as Bacillus megaterium. The biological properties of 3-acetamido--3,6-dideoxy--D--galactose have been studied using monoclonal antibodies, magnetic resonance spectroscopy (MRS), and 13C nuclear magnetic resonance spectroscopy (NMR).

Please enquire for more information about N-(Formylamidino)-N-b-D-ribofuranosylurea including the price, delivery time and more detailed product information at the technical inquiry form on this page

2,4-Dinitrophenyl 3,4,6-tri-O-acetyl-2-deoxy-2-fluoro-b-D-galactoside is a glycosidase inhibitor that is used in the validation of β-glucosidases. It has been shown to inhibit the activity of a number of glycosidases, including α-, β-, and γ-. 2,4-Dinitrophenyl 3,4,6-tri-O-acetyl -2 -deoxy -2 -fluoro -b D galactoside inhibits the hydrolysis of oligosaccharides containing a terminal α-- or β--glucose moiety to produce smaller sugars. This compound can be used as an acceptor for spectrophotometric assays and as an analytical standard for measuring the degree of polymerization (DP) of oligosaccharides. The rate of its reaction with gly

Forodesine is a purine nucleoside that inhibits the nucleoside phosphorylase enzyme and prevents the synthesis of purines. It has minimal toxicity and is effective against intracellular targets such as mitochondria, which are important for apoptosis induction. Forodesine also inhibits the mcl-1 protein, which is an inhibitor of t-cell lymphomas. This drug has been shown to be effective in animal models of human lymphoma and leukemia.